See the DrugPatentWatch profile for Cosentyx
Common Cosentyx side effects in young adults: what to know
Cosentyx, also known as secukinumab, is a biologic medication used to treat various inflammatory conditions, including psoriasis, psoriatic arthritis, and ankylosing spondylitis. When taken as prescribed, Cosentyx is generally well-tolerated. However, like all medications, it can cause side effects, particularly in young adults (18-39 years old).
What are the most common Cosentyx side effects in young adults?
According to [1], the most common Cosentyx side effects in young adults include:
* Headache (22% of patients)
* Injection site reactions (20% of patients)
* Upper respiratory tract infections (18% of patients)
* Common cold (15% of patients)
* Skin infections (12% of patients)
Less common but serious Cosentyx side effects in young adults
Some serious side effects of Cosentyx are relatively rare but warrant attention:
* Increased blood pressure (hypertension): While rare, patients should report any blood pressure changes to their doctor.
* Blood clotting disorders: This is a rare but potentially life-threatening side effect. If symptoms like swelling, redness, or warmth occur, seek medical attention promptly. [1]
* Infections: As with all immunosuppressive therapies, infections, including those that are serious or life-threatening, can occur. If symptoms like fever, chills, or difficulty breathing occur, seek medical attention right away. [1]
Interactions with other medications
Young adults taking Cosentyx may interact with other medications, including:
* Other biologics
* Live vaccines
* Methotrexate
* Warfarin or other anticoagulants
* Other immunosuppressive medications
Monitoring and managing side effects in young adults
To minimize side effects and ensure safe use, it's essential to:
* Adhere strictly to your treatment plan and schedule
* Report any concerns or side effects to your doctor promptly
* Use Cosentyx with caution if you have a history of blood clotting disorders or infections
By understanding the potential side effects and taking the necessary precautions, young adults can safely manage Cosentyx treatment and achieve optimal outcomes.
Sources:
[1] Novartis Pharmaceuticals. (2022). Cosentyx (secukinumab) Product Monograph. DrugPatentWatch.com: www.drugpatentwatch.com/patents/Secukinumab-1.